Cas:1305320-62-0 2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethanamine manufacturer & supplier

Chemical Name:2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethanamine

CAS.NO:1305320-62-0

Synonyms:2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethanamine

Molecular Formula:C₁₅H₁₃Cl₄NO

Molecular Weight:365.08200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:35.25000

Exact Mass:362.97500

LogP:6.21710

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethanamine Use and application,2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethanamine technical grade,usp/ep/jp grade.

Related News: A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market. 3-methyl-2-pyridin-2-ylbutanenitrile manufacturers Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD welcomed the announcement, saying: “I’m really pleased that Ballina will play such an important role in the production of COVID-19 vaccines, which have saved millions of lives around the world. Methylene-Bis Paroxetine suppliers Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD welcomed the announcement, saying: “I’m really pleased that Ballina will play such an important role in the production of COVID-19 vaccines, which have saved millions of lives around the world. 2-(7-methyl-2-oxo-1,3-dihydroindol-3-yl)acetic acid vendor & factory Building on this progress, recombinant technologies have been key to optimizing the performance of biocatalytic reagents, for example by facilitating a reduction in the amount of enzyme needed to drive a reaction while at the same time increasing the yield. ,Building on this progress, recombinant technologies have been key to optimizing the performance of biocatalytic reagents, for example by facilitating a reduction in the amount of enzyme needed to drive a reaction while at the same time increasing the yield.